CervoMed’s neflamapimod elected for inclusion in UK EXPERTS-ALS platform designed to prioritize promising treatments for Amyotrophic Lateral SclerosisNeflamapimod endorsement based on targeted mechanism of action, demonstrated clinical activity in neurodegenerative diseases, and encouraging translational data in ALS-relevant neurotoxicity models
Peraso (NASDAQ: PRSO) Powers Military, Nex-Gen Broadband Surge – Mag 7 Undercard VAPE CELC, CRVO – More Stocks InsidePeraso Inc. (
NASDAQ: PRSO), a leader in 60GHz mmWave wireless technology, is rapidly expanding its global footprint through dual momentum in defense and broadband sectors. In a key commercial milestone, Tachyon Networks has selected Peraso’s PRM2141X module for its new TNA-303L-65 —a compact outdoor wireless solution delivering fiber-class speeds up to 1 Gbps across 3+ km, without the need for costly trenching.
